{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:57:26Z","timestamp":1790200646101,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T00:00:00Z","timestamp":1652832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["91949117"],"award-info":[{"award-number":["91949117"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31871044"],"award-info":[{"award-number":["31871044"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001276"],"award-info":[{"award-number":["82001276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ischemia-induced neuronal death leads to serious lifelong neurological deficits in ischemic stroke patients. Histone deacetylase 6 (HDAC6) is a promising target for neuroprotection in many neurological disorders, including ischemic stroke. However, the mechanism by which HDAC6 inhibition protects neurons after ischemic stroke remains unclear. Here, we discovered that genetic ablation or pharmacological inhibition of HDAC6 reduced brain injury after ischemic stroke by increasing macrophage migration inhibitory factor (MIF) acetylation. Mass spectrum analysis and biochemical results revealed that HDAC6 inhibitor or aspirin treatment promoted MIF acetylation on the K78 residue. MIF K78 acetylation suppressed the interaction between MIF and AIF, which impaired MIF translocation to the nucleus in ischemic cortical neurons. Moreover, neuronal DNA fragmentation and neuronal death were impaired in the cortex after ischemia in MIF K78Q mutant mice. Our results indicate that the neuroprotective effect of HDAC6 inhibition and aspirin treatment results from MIF K78 acetylation; thus, MIF K78 acetylation may be a therapeutic target for ischemic stroke and other neurological diseases.<\/jats:p>","DOI":"10.1038\/s41419-022-04918-2","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T04:02:57Z","timestamp":1652846577000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Macrophage migration inhibitory factor (MIF) acetylation protects neurons from ischemic injury"],"prefix":"10.1038","volume":"13","author":[{"given":"Jin-Xia","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ying","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Nan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Yong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Min","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Ru","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian-Qian","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Chun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Yun","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9542-4767","authenticated-orcid":false,"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,18]]},"reference":[{"key":"4918_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1042\/bj0870258","volume":"87","author":"DM Phillips","year":"1963","unstructured":"Phillips DM. The presence of acetyl groups of histones. Biochemical J. 1963;87:258\u201363.","journal-title":"Biochemical J"},{"key":"4918_CR2","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1073\/pnas.51.5.786","volume":"51","author":"VG Allfrey","year":"1964","unstructured":"Allfrey VG, Faulkner R, Mirsky AE. Acetylation and methylation of histones and their possible role in the regulation of Rna synthesis. Proc Natl Acad Sci USA. 1964;51:786\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4918_CR3","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/38664","volume":"389","author":"M Grunstein","year":"1997","unstructured":"Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 1997;389:349\u201352.","journal-title":"Nature"},{"key":"4918_CR4","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.molcel.2006.06.026","volume":"23","author":"SC Kim","year":"2006","unstructured":"Kim SC, Sprung R, Chen Y, Xu Y, Ball H, Pei J, et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol cell. 2006;23:607\u201318.","journal-title":"Mol cell"},{"key":"4918_CR5","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1126\/science.1179689","volume":"327","author":"S Zhao","year":"2010","unstructured":"Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, et al. Regulation of cellular metabolism by protein lysine acetylation. Science. 2010;327:1000\u20134.","journal-title":"Science"},{"key":"4918_CR6","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1126\/science.1175371","volume":"325","author":"C Choudhary","year":"2009","unstructured":"Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, et al. Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009;325:834\u201340.","journal-title":"Science"},{"key":"4918_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/nrm3931","volume":"16","author":"E Verdin","year":"2015","unstructured":"Verdin E, Ott M. 50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond. Nat Rev Mol Cell Biol. 2015;16:258\u201364.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"4918_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.molcel.2007.05.033","volume":"27","author":"X Zhang","year":"2007","unstructured":"Zhang X, Yuan Z, Zhang Y, Yong S, Salas-Burgos A, Koomen J, et al. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell. 2007;27:197\u2013213.","journal-title":"Mol Cell"},{"key":"4918_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/417455a","volume":"417","author":"C Hubbert","year":"2002","unstructured":"Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, et al. HDAC6 is a microtubule-associated deacetylase. Nature. 2002;417:455\u20138.","journal-title":"Nature"},{"key":"4918_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.molcel.2005.04.021","volume":"18","author":"JJ Kovacs","year":"2005","unstructured":"Kovacs JJ, Murphy PJ, Gaillard S, Zhao X, Wu JT, Nicchitta CV, et al. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Mol Cell. 2005;18:601\u20137.","journal-title":"Mol Cell"},{"key":"4918_CR11","doi-asserted-by":"publisher","first-page":"9633","DOI":"10.1073\/pnas.0803749105","volume":"105","author":"RB Parmigiani","year":"2008","unstructured":"Parmigiani RB, Xu WS, Venta-Perez G, Erdjument-Bromage H, Yaneva M, Tempst P, et al. HDAC6 is a specific deacetylase of peroxiredoxins and is involved in redox regulation. Proc Natl Acad Sci USA. 2008;105:9633\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4918_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3233\/JAD-2012-120727","volume":"33","author":"L Zhang","year":"2013","unstructured":"Zhang L, Sheng S, Qin C. The role of HDAC6 in Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2013;33:283\u201395.","journal-title":"J Alzheimer\u2019s Dis"},{"key":"4918_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6245","volume":"5","author":"VK Godena","year":"2014","unstructured":"Godena VK, Brookes-Hocking N, Moller A, Shaw G, Oswald M, Sancho RM, et al. Increasing microtubule acetylation rescues axonal transport and locomotor deficits caused by LRRK2 Roc-COR domain mutations. Nat Commun. 2014;5:5245.","journal-title":"Nat Commun"},{"key":"4918_CR14","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","volume":"27","author":"JP Dompierre","year":"2007","unstructured":"Dompierre JP, Godin JD, Charrin BC, Cordelieres FP, King SJ, Humbert S, et al. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington\u2019s disease by increasing tubulin acetylation. J Neurosci. 2007;27:3571\u201383.","journal-title":"J Neurosci"},{"key":"4918_CR15","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1093\/hmg\/ddt028","volume":"22","author":"I Taes","year":"2013","unstructured":"Taes I, Timmers M, Hersmus N, Bento-Abreu A, Van Den Bosch L, Van Damme P, et al. Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS. Hum Mol Genet. 2013;22:1783\u201390.","journal-title":"Hum Mol Genet"},{"key":"4918_CR16","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nm.2396","volume":"17","author":"C d\u2019Ydewalle","year":"2011","unstructured":"d\u2019Ydewalle C, Krishnan J, Chiheb DM, Van Damme P, Irobi J, Kozikowski AP, et al. HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat Med. 2011;17:968\u201374.","journal-title":"Nat Med"},{"key":"4918_CR17","doi-asserted-by":"crossref","first-page":"9475981","DOI":"10.1155\/2016\/9475981","volume":"2016","author":"JY Kim","year":"2016","unstructured":"Kim JY, Woo SY, Hong YB, Choi H, Kim J, Choi H, et al. HDAC6 inhibitors rescued the defective axonal mitochondrial movement in motor neurons derived from the induced pluripotent stem cells of peripheral neuropathy patients with HSPB1 mutation. Stem Cells Int. 2016;2016:9475981.","journal-title":"Stem Cells Int"},{"key":"4918_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/srep19626","volume":"6","author":"Z Wang","year":"2016","unstructured":"Wang Z, Leng Y, Wang J, Liao HM, Bergman J, Leeds P, et al. Tubastatin A, an HDAC6 inhibitor, alleviates stroke-induced brain infarction and functional deficits: potential roles of alpha-tubulin acetylation and FGF-21 up-regulation. Sci Rep. 2016;6:19626.","journal-title":"Sci Rep."},{"key":"4918_CR19","doi-asserted-by":"publisher","first-page":"12673","DOI":"10.1523\/JNEUROSCI.0016-12.2012","volume":"32","author":"L Li","year":"2012","unstructured":"Li L, Wei D, Wang Q, Pan J, Liu R, Zhang X, et al. MEC-17 deficiency leads to reduced alpha-tubulin acetylation and impaired migration of cortical neurons. J Neurosci. 2012;32:12673\u201383.","journal-title":"J Neurosci"},{"key":"4918_CR20","doi-asserted-by":"publisher","first-page":"3332","DOI":"10.1093\/cercor\/bhx225","volume":"28","author":"W Dan","year":"2018","unstructured":"Dan W, Gao N, Li L, Zhu JX, Diao L, Huang J, et al. alpha-Tubulin acetylation restricts axon overbranching by dampening microtubule plus-end dynamics in neurons. Cereb Cortex. 2018;28:3332\u201346.","journal-title":"Cereb Cortex"},{"key":"4918_CR21","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1016\/j.cell.2018.05.018","volume":"173","author":"MM Magiera","year":"2018","unstructured":"Magiera MM, Singh P, Gadadhar S, Janke C. Tubulin posttranslational modifications and emerging links to human disease. Cell. 2018;173:1323\u20137.","journal-title":"Cell"},{"key":"4918_CR22","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1096\/fasebj.14.7.955","volume":"14","author":"J Cui","year":"2000","unstructured":"Cui J, Holmes EH, Greene TG, Liu PK. Oxidative DNA damage precedes DNA fragmentation after experimental stroke in rat brain. FASEB J. 2000;14:955\u201367.","journal-title":"FASEB J"},{"key":"4918_CR23","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/nm1097-1089","volume":"3","author":"MJ Eliasson","year":"1997","unstructured":"Eliasson MJ, Sampei K, Mandir AS, Hurn PD, Traystman RJ, Bao J, et al. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nat Med. 1997;3:1089\u201395.","journal-title":"Nat Med"},{"key":"4918_CR24","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1126\/science.1072221","volume":"297","author":"SW Yu","year":"2002","unstructured":"Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, et al. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science. 2002;297:259\u201363.","journal-title":"Science"},{"key":"4918_CR25","doi-asserted-by":"publisher","first-page":"aad6872.","DOI":"10.1126\/science.aad6872","volume":"354","author":"Y Wang","year":"2016","unstructured":"Wang Y, An R, Umanah GK, Park H, Nambiar K, Eacker SM, et al. A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1. Science. 2016;354:aad6872.","journal-title":"Science"},{"key":"4918_CR26","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev-pharmtox-010716-105001","volume":"57","author":"TM Dawson","year":"2017","unstructured":"Dawson TM, Dawson VL. Mitochondrial mechanisms of neuronal cell death: potential therapeutics. Annu Rev Pharmacol Toxicol. 2017;57:437\u201354.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"4918_CR27","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1128\/MCB.01154-06","volume":"28","author":"Y Zhang","year":"2008","unstructured":"Zhang Y, Kwon S, Yamaguchi T, Cubizolles F, Rousseaux S, Kneissel M, et al. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol Cell Biol. 2008;28:1688\u2013701.","journal-title":"Mol Cell Biol"},{"key":"4918_CR28","first-page":"971","volume":"7","author":"DM Vigushin","year":"2001","unstructured":"Vigushin DM, Ali S, Pace PE, Mirsaidi N, Ito K, Adcock I, et al. Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. Clin Cancer Res. 2001;7:971\u20136.","journal-title":"Clin Cancer Res"},{"key":"4918_CR29","doi-asserted-by":"publisher","first-page":"6820","DOI":"10.1093\/emboj\/cdf682","volume":"21","author":"A Matsuyama","year":"2002","unstructured":"Matsuyama A, Shimazu T, Sumida Y, Saito A, Yoshimatsu Y, Seigneurin-Berny D, et al. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J. 2002;21:6820\u201331.","journal-title":"EMBO J"},{"key":"4918_CR30","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1073\/pnas.0430973100","volume":"100","author":"SJ Haggarty","year":"2003","unstructured":"Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci USA. 2003;100:4389\u201394.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4918_CR31","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1161\/STR.0000000000000158","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke. 2018;49:e46\u2013e110.","journal-title":"Stroke"},{"key":"4918_CR32","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1056\/NEJM199405053301808","volume":"330","author":"C Patrono","year":"1994","unstructured":"Patrono C. Aspirin as an antiplatelet drug. N Engl J Med. 1994;330:1287\u201394.","journal-title":"N Engl J Med"},{"key":"4918_CR33","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1126\/science.274.5291.1383","volume":"274","author":"M Grilli","year":"1996","unstructured":"Grilli M, Pizzi M, Memo M, Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science. 1996;274:1383\u20135.","journal-title":"Science"},{"key":"4918_CR34","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1046\/j.1471-4159.2001.00600.x","volume":"79","author":"J De Cristobal","year":"2001","unstructured":"De Cristobal J, Moro MA, Davalos A, Castillo J, Leza JC, Camarero J, et al. Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats. J Neurochem. 2001;79:456\u20139.","journal-title":"J Neurochem"},{"key":"4918_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1161\/hs0102.101299","volume":"33","author":"J De Cristobal","year":"2002","unstructured":"De Cristobal J, Cardenas A, Lizasoain I, Leza JC, Fernandez-Tome P, Lorenzo P, et al. Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation. Stroke. 2002;33:261\u20137.","journal-title":"Stroke"},{"key":"4918_CR36","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1074\/mcp.O116.065219","volume":"16","author":"MH Tatham","year":"2017","unstructured":"Tatham MH, Cole C, Scullion P, Wilkie R, Westwood NJ, Stark LA, et al. A poroteomic approach to analyze the aspirin-mediated lysine acetylome. Mol Cell Proteom. 2017;16:310\u201326.","journal-title":"Mol Cell Proteom"},{"key":"4918_CR37","first-page":"533","volume":"2","author":"LF Alfonso","year":"2009","unstructured":"Alfonso LF, Srivenugopal KS, Bhat GJ. Does aspirin acetylate multiple cellular proteins? (Review). Mol Med Rep. 2009;2:533\u20137.","journal-title":"Mol Med Rep."},{"key":"4918_CR38","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.cell.2019.01.016","volume":"176","author":"J Dai","year":"2019","unstructured":"Dai J, Huang YJ, He X, Zhao M, Wang X, Liu ZS, et al. Acetylation blocks cGAS activity and inhibits self-DNA-induced autoimmunity. Cell. 2019;176:1447\u201360.","journal-title":"Cell"},{"key":"4918_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-62678-5","volume":"10","author":"L Francelle","year":"2020","unstructured":"Francelle L, Outeiro TF, Rappold GA. Inhibition of HDAC6 activity protects dopaminergic neurons from alpha-synuclein toxicity. Sci Rep. 2020;10:6064.","journal-title":"Sci Rep."},{"key":"4918_CR40","doi-asserted-by":"publisher","first-page":"105141","DOI":"10.1016\/j.neuint.2021.105141","volume":"149","author":"Y Du","year":"2021","unstructured":"Du Y, Yang X, Li Z, Le W, Hao Y, Song Y, et al. HDAC6-mediated Hsp90 deacetylation reduces aggregation and toxicity of the protein alpha-synuclein by regulating chaperone-mediated autophagy. Neurochem Int. 2021;149:105141.","journal-title":"Neurochem Int"},{"key":"4918_CR41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0006-8993(02)04243-9","volume":"967","author":"K Krapfenbauer","year":"2003","unstructured":"Krapfenbauer K, Engidawork E, Cairns N, Fountoulakis M, Lubec G. Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders. Brain Res. 2003;967:152\u201360.","journal-title":"Brain Res"},{"key":"4918_CR42","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nm.2749","volume":"18","author":"T Shichita","year":"2012","unstructured":"Shichita T, Hasegawa E, Kimura A, Morita R, Sakaguchi R, Takada I, et al. Peroxiredoxin family proteins are key initiators of post-ischemic inflammation in the brain. Nat Med. 2012;18:911\u20137.","journal-title":"Nat Med"},{"key":"4918_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2017.415","volume":"8","author":"J Leyk","year":"2017","unstructured":"Leyk J, Daly C, Janssen-Bienhold U, Kennedy BN, Richter-Landsberg C. HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness. Cell Death Dis. 2017;8:e3028.","journal-title":"Cell Death Dis"},{"key":"4918_CR44","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41569-019-0225-y","volume":"16","author":"C Patrono","year":"2019","unstructured":"Patrono C, Baigent C. Role of aspirin in primary prevention of cardiovascular disease. Nat Rev Cardiol. 2019;16:675\u201386.","journal-title":"Nat Rev Cardiol"},{"key":"4918_CR45","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1080\/09537104.2018.1492105","volume":"29","author":"P Patrignani","year":"2018","unstructured":"Patrignani P, Patrono C. Aspirin, platelet inhibition and cancer prevention. Platelets. 2018;29:779\u201385.","journal-title":"Platelets"},{"key":"4918_CR46","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.ejphar.2010.02.046","volume":"635","author":"H Kato","year":"2010","unstructured":"Kato H, Yoshimoto K, Kobayashi M, Sakabe M, Funaki H, Ikegaya H. Oral administration of ethanol with aspirin increases the concentration of salicylic acid in plasma and organs, especially the brain, in mice. Eur J Pharm. 2010;635:184\u20137.","journal-title":"Eur J Pharm"},{"key":"4918_CR47","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.expneurol.2017.06.021","volume":"301","author":"MF Leyton-Jaimes","year":"2018","unstructured":"Leyton-Jaimes MF, Kahn J, Israelson A. Macrophage migration inhibitory factor: a multifaceted cytokine implicated in multiple neurological diseases. Exp Neurol. 2018;301:83\u201391.","journal-title":"Exp Neurol"},{"key":"4918_CR48","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1073\/pnas.56.1.72","volume":"56","author":"JR David","year":"1966","unstructured":"David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA. 1966;56:72\u201377.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4918_CR49","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1038\/nature06504","volume":"451","author":"EJ Miller","year":"2008","unstructured":"Miller EJ, Li J, Leng L, McDonald C, Atsumi T, Bucala R, et al. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature. 2008;451:578\u201382.","journal-title":"Nature"},{"key":"4918_CR50","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.neuron.2015.02.034","volume":"86","author":"A Israelson","year":"2015","unstructured":"Israelson A, Ditsworth D, Sun S, Song S, Liang J, Hruska-Plochan M, et al. Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1. Neuron. 2015;86:218\u201332.","journal-title":"Neuron"},{"key":"4918_CR51","doi-asserted-by":"publisher","first-page":"10198","DOI":"10.1073\/pnas.1604600113","volume":"113","author":"MF Leyton-Jaimes","year":"2016","unstructured":"Leyton-Jaimes MF, Benaim C, Abu-Hamad S, Kahn J, Guetta A, Bucala R, et al. Endogenous macrophage migration inhibitory factor reduces the accumulation and toxicity of misfolded SOD1 in a mouse model of ALS. Proc Natl Acad Sci USA. 2016;113:10198\u2013203.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4918_CR52","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1096\/fj.14-253625","volume":"28","author":"S Zhang","year":"2014","unstructured":"Zhang S, Zis O, Ly PT, Wu Y, Zhang S, Zhang M, et al. Down-regulation of MIF by NFkappaB under hypoxia accelerated neuronal loss during stroke. FASEB J. 2014;28:4394\u2013407.","journal-title":"FASEB J"},{"key":"4918_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-75","volume":"8","author":"AR Inacio","year":"2011","unstructured":"Inacio AR, Bucala R, Deierborg T. Lack of macrophage migration inhibitory factor in mice does not affect hallmarks of the inflammatory\/immune response during the first week after stroke. J Neuroinflammation. 2011;8:75.","journal-title":"J Neuroinflammation"},{"key":"4918_CR54","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.neuron.2016.10.023","volume":"92","author":"L Li","year":"2016","unstructured":"Li L, Cao Y, Wu H, Ye X, Zhu Z, Xing G, et al. Enzymatic activity of the scaffold protein rapsyn for synapse formation. Neuron. 2016;92:1007\u201319.","journal-title":"Neuron"},{"key":"4918_CR55","doi-asserted-by":"publisher","first-page":"8637","DOI":"10.1128\/MCB.00393-07","volume":"27","author":"YS Gao","year":"2007","unstructured":"Gao YS, Hubbert CC, Lu J, Lee YS, Lee JY, Yao TP. Histone deacetylase 6 regulates growth factor-induced actin remodeling and endocytosis. Mol Cell Biol. 2007;27:8637\u201347.","journal-title":"Mol Cell Biol"},{"key":"4918_CR56","first-page":"50370.","volume":"76","author":"V Labat-gest","year":"2013","unstructured":"Labat-gest V, Tomasi S. Photothrombotic ischemia: a minimally invasive and reproducible photochemical cortical lesion model for mouse stroke studies. J Vis Exp. 2013;76:50370.","journal-title":"J Vis Exp"},{"key":"4918_CR57","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1161\/STROKEAHA.117.018115","volume":"49","author":"XC Ye","year":"2018","unstructured":"Ye XC, Hu JX, Li L, Li Q, Tang FL, Lin S, et al. Astrocytic Lrp4 (low-density lipoprotein receptor-related protein 4) contributes to ischemia-induced brain injury by regulating ATP release and adenosine-A2AR (Adenosine A2A Receptor) signaling. Stroke. 2018;49:165\u201374.","journal-title":"Stroke"},{"key":"4918_CR58","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1161\/STROKEAHA.111.627174","volume":"42","author":"J Chen","year":"2011","unstructured":"Chen J, Ye X, Yan T, Zhang C, Yang XP, Cui X, et al. Adverse effects of bone marrow stromal cell treatment of stroke in diabetic rats. Stroke. 2011;42:3551\u20138.","journal-title":"Stroke"},{"key":"4918_CR59","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.expneurol.2011.09.022","volume":"232","author":"X Ye","year":"2011","unstructured":"Ye X, Chopp M, Cui X, Zacharek A, Cui Y, Yan T, et al. Niaspan enhances vascular remodeling after stroke in type 1 diabetic rats. Exp Neurol. 2011;232:299\u2013308.","journal-title":"Exp Neurol"},{"key":"4918_CR60","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/nprot.2009.125","volume":"4","author":"V Bouet","year":"2009","unstructured":"Bouet V, Boulouard M, Toutain J, Divoux D, Bernaudin M, Schumann-Bard P, et al. The adhesive removal test: a sensitive method to assess sensorimotor deficits in mice. Nat Protoc. 2009;4:1560\u20134.","journal-title":"Nat Protoc"},{"key":"4918_CR61","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.expneurol.2004.01.004","volume":"187","author":"X Li","year":"2004","unstructured":"Li X, Blizzard KK, Zeng Z, DeVries AC, Hurn PD, McCullough LD. Chronic behavioral testing after focal ischemia in the mouse: functional recovery and the effects of gender. Exp Neurol. 2004;187:94\u2013104.","journal-title":"Exp Neurol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04918-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T08:24:29Z","timestamp":1727252669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-022-04918-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,18]]},"references-count":61,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5]]}},"alternative-id":["4918"],"URL":"https:\/\/doi.org\/10.1038\/s41419-022-04918-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,18]]},"assertion":[{"value":"8 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"466"}}